Los Angeles Cancer Network and START Partner to Expand Access to Early Phase Oncology Trials
Los Angeles Cancer Network and START Partner to Expand Access to Early Phase Oncology Trials
As part of a strategic partnership with START Center for Cancer Research, the physicians at Los Angeles Cancer Network will begin offering early-phase clinical trials to our patients beginning in early 2026.
LACN’s partnership with START will improve clinical trial options for many patients in the Southern California, and it will also create an efficient model for faster and more scalable drug development.
START, recognized globally as the largest early-phase oncology research network, operates 10 clinical trial sites worldwide, with 31 Principal Investigators overseeing more than 700 early-phase clinical trials. Since its inception, START has contributed directly to the development and FDA/EMA approval of over 45 groundbreaking cancer therapies.
Troy Simon, CEO of the Los Angeles Cancer Network, stated, “Our partnership with START will redefine possibilities for patients in Southern California, offering timely access to groundbreaking trials and treatments.”
